Deals
Orexigen Therapeutics Raises $165M at 7% Premium
|
Orexigen Therapeutics (NASDAQ GS:OREX) announced that it has raised $165,000,000 in a Convertible Senior Secured Notes transaction.
Growth Capitalist (https://growthcapitalist.com/category/deals/page/34/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
Orexigen Therapeutics (NASDAQ GS:OREX) announced that it has raised $165,000,000 in a Convertible Senior Secured Notes transaction.
InVivo Therapeutics Holdings Corporation (NASDAQ GM:NVIV) announced that it has raised $27,999,998 in a CMPO/Overnight transaction
Capricor Therapeutics(NASDAQ CM:CAPR) announced that it has raised $4,061,162 in a Registered Direct transaction.
MoSys (NASDAQ GS:MOSY) announced that it has raised $8,000,000 in a Convertible Senior Secured Notes transaction.